Jia Jie Biomedical Co Ltd (4109) — Cash Flow Quality Index
Jia Jie Biomedical Co Ltd (4109) has a Cash Flow Quality Index of 0.41x as of December 2025. Operating cash flow of NT$11.32 Million is below net income of NT$27.33 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Jia Jie Biomedical Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jia Jie Biomedical Co Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Jia Jie Biomedical Co Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 4109 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jia Jie Biomedical Co Ltd (2015–2025)
Year-by-year earnings quality comparison for Jia Jie Biomedical Co Ltd. For live market cap and the full company financial profile, see 4109 stock market capitalisation.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | NT$21.34 Million | NT$50.26 Million | ▲ +102.4% |
| 2024 | 0.21x | NT$44.35 Million | NT$211.37 Million | ▲ +785.1% |
| 2023 | -0.03x | NT$-4.49 Million | NT$146.55 Million | ▼ -103.7% |
| 2021 | 0.83x | NT$4.37 Million | NT$5.29 Million | ▲ +115.6% |
| 2018 | -5.29x | NT$-13.10 Million | NT$2.47 Million | ▲ +19.6% |
| 2016 | -6.58x | NT$-76.54 Million | NT$11.63 Million | ▼ -402.9% |
| 2015 | 2.17x | NT$82.22 Million | NT$37.84 Million | — |